Harnessing power of immune system for therapies against cancer

Innovative immunotherapies treatments for advanced or high-risk melanoma and cervical cancer -- used alone or in combination -- fight cancer by activating and amplifying the body's immune response to the disease. New studies find high activity with investigative drugs for advanced melanoma, and show for the first time that ipilimumab, a treatment already approved for advanced melanoma, can substantially decrease the risk of melanoma recurrence in certain patients with earlier-stage disease.

Read the whole article on Science Daily

More from Science Daily